← Leaderboards
Yuri Sykulev
Thomas Jefferson University
$9,058,653
Attributed
$12,428,514
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,703,514 · 14
By mechanism
R01$7,671,059 · 4
U01$2,546,456 · 1
R21$1,524,249 · 4
S10$550,000 · 4
R56$411,750 · 1
Top collaborators
- Kerry S Campbell5 shared
- Lorraine Iacovitti5 shared
- Alexander M Mazo5 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Kerry S Campbell$9,648,609
- Lorraine Iacovitti$10,800,609
- Alexander M Mazo$10,970,170
- Michael Lawler$94,446
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteCellsProteinsMolecularCd8b1 GeneBaseSignal TransductionReceptorVirusPeptide/Mhc ComplexNovel StrategiesCell SurfaceVariantSurfaceMediatingAntigensNatural Killer CellsCytolysisIntercellular Adhesion Molecule 1ResponseLymphocyteCytotoxicNanoparticleImmunologic Receptors
Grant awards (38)
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells$498,670
U01 · FY2024 · AI · contact PI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells$502,627
U01 · FY2023 · AI · contact PI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells$506,466
U01 · FY2022 · AI · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2021 · AI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells$510,193
U01 · FY2021 · AI · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2020 · AI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells$528,500
U01 · FY2020 · AI · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2019 · AI
Defining optimal TCR-pMHC interactions: implication for designing new T-cell based therapeutics to treat viral infections and cancer$156,000
R01 · FY2019 · CA · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2018 · AI
Defining optimal TCR-pMHC interactions: implication for designing new T-cell based therapeutics to treat viral infections and cancer$156,000
R01 · FY2018 · CA · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$530,358
R01 · FY2017 · AI
Defining optimal TCR-pMHC interactions: implication for designing new T-cell based therapeutics to treat viral infections and cancer$156,000
R01 · FY2017 · CA · contact PI
Exploiting an artificial APC to induce different T cell subsets$207,321
R21 · FY2016 · AI · contact PI
Exploiting an artificial APC to induce different T cell subsets$260,487
R21 · FY2015 · AI · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$396,381
R01 · FY2012 · AI · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$389,223
R01 · FY2011 · AI · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$79,301
R01 · FY2011 · AI · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$393,154
R01 · FY2010 · AI · contact PI
Proximity between immune receptors on the cell surface and the sensitivity of Tce$142,700
R21 · FY2010 · CA · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$397,125
R01 · FY2009 · AI · contact PI
Proximity between immune receptors on the cell surface and the sensitivity of Tce$190,315
R21 · FY2009 · CA · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$171,388
R01 · FY2008 · AI · contact PI
Immune Receptors on Cytotoxic Lymphocytes and Target Cells$411,750
R56 · FY2007 · AI · contact PI
Immune receptors on Cytotoxic Lymphocytes& Target Cell$327,616
R01 · FY2006 · AI · contact PI
Immune receptors on Cytotoxic Lymphocytes&Target Cell$335,500
R01 · FY2005 · AI
Soluble oligomeric TCR and antigen presentation to CTL$235,500
R21 · FY2005 · AI
Immune receptors on Cytotoxic Lymphocytes&Target Cell$335,500
R01 · FY2004 · AI
Jefferson Shared Biacore Instrumentation$275,000
S10 · FY2004 · RR
Soluble oligomeric TCR and antigen presentation to CTL$209,850
R21 · FY2004 · AI
JEFFERSON SHARED BIACORE INSTRUMENTATION: GENETICS$110,000
S10 · FY2004 · RR
JEFFERSON SHARED BIACORE INSTRUMENTATION: CANCER$110,000
S10 · FY2004 · RR
JEFFERSON SHARED BIACORE INSTRUMENTATION: AIDS$55,000
S10 · FY2004 · RR
Immune receptors on Cytotoxic Lymphocytes&Target Cell$335,500
R01 · FY2003 · AI
Immune receptors on Cytotoxic Lymphocytes&Target Cell$349,750
R01 · FY2002 · AI
FACTORS LIMITING ANTI HIV RESPONSES OF CYTOTOXIC T CELLS$278,076
R21 · FY2002 · AI
FACTORS LIMITING ANTIHIV RESPONSES OF CYTOTOXIC T CELLS$277,882
R01 · FY2001 · AI
FACTORS LIMITING ANTIHIV RESPONSES OF CYTOTOXIC T CELLS$269,789
R01 · FY2000 · AI